具有可重编程药物分配功能的磁性微型软机器人:朝着先进的有针对性的组合疗法发展
Zilin Yang1, Changyu Xu1, Jia Xin Lee2
1School of Mechanical and Aerospace Engineering, Nanyang Technological University, 50 Nanyang Avenue, Singapore, 639798, Singapore.
Advanced materials (Deerfield Beach, Fla.)
|September 9, 2024
概括
一个新的毫米级软机器人可以精确地在向组合治疗中输送四种药物. 这种无绑定执行器提供可重编程的药物递送序列和剂量,用于先进的医疗治疗.
科学领域:
- 生物医学工程 生物医学工程
- 机器人技术 机器人技术 机器人技术
- 材料科学 材料科学 材料科学
背景情况:
- 微型机器人为有针对性的药物输送提供了潜力,提高了治疗效率并减少了并发症.
- 目前的微型机器人缺乏先进的向组合疗法的能力,因为它们受到药物容量,分发控制和多地点分发的限制.
- 现有的多药机器人无法调整药物序列,剂量或在多个位置选择性地分发药物.
研究的目的:
- 开发一个能够进行先进的向组合治疗的毫米级软机器人.
- 为了实现多种药物的精确,可编程的输送,可调节序列和剂量.
- 为了克服现有的微型机器人在药物输送精度和多功能性方面的局限性.
主要方法:
- 由交替磁场驱动的毫米级软机器人被设计和制造.
- 机器人被设计为六个自由度的运动,包括滚动和双爬.
- 配送四种类型的药物的能力与可重编程序列和剂量被整合.
主要成果:
- 软机器人成功地分发了四种类型的药物,并控制了剂量 (0.0992-0.231μL h-1).
- 机器人展示了精确的导航和药物输送到无结构环境中的多个站点.
- 在移动和处方期间观察到微不足道的药物泄漏,突出显示了其可靠性.
结论:
- 拟议的毫米尺度软机器人代表了微型机器人药物递送技术的重大进步.
- 这项技术使先进的有针对性的多种药物联合治疗具有前所未有的灵活性.
- 机器人的能力具有巨大的潜力,可以彻底改变个性化医疗和复杂的治疗策略.
相关概念视频
Modified-Release Drug Delivery Systems: Rate-Programmed II
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
Modified-Release Drug Delivery Systems: Classification
Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...
Modified-Release Drug Delivery Systems: Rate-Programmed I
Rate-programmed drug delivery systems (DDS) are designed to release drugs at specific, controlled rates to maintain consistent therapeutic levels. These systems are categorized based on their release mechanisms, including dissolution-controlled DDS, diffusion-controlled DDS, and combined dissolution-diffusion-controlled DDS.In dissolution-controlled DDS, the release rate depends on the slow dissolution of the drug itself or the surrounding matrix. Drugs with inherently slow dissolution rates,...
Modified-Release Drug Delivery Systems: Stimuli-Activated
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also called...
Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...


